Early clinical results presented by surgeons at the 2016 annual meeting of the North American Spine Society (NASS) have shown high fusion rates at six months as well as beneficial clinical outcomes, for most patients, when PEEK-OPTIMA HA Enhanced is used for interbody-fusion devices.
The implantable high-performance polymer, from Invibio Biomaterial Solutions, combines PEEK-OPTIMA and hydroxyapatite (HA), an osteoconductive material that enhances bone apposition, and is fully integrated.
Previous studies by Invibio have highlighted that enhancing bone apposition on all surfaces of an interbody-fusion device may offer better integration and improved potential for spinal fusion.
“The findings on first clinical cases for PEEK-OPTIMA HA Enhanced presented at the NASS 2016 annual meeting are demonstrating the Invibio goal of providing solutions that have the potential to improve clinical outcomes and advance bone apposition in interbody-fusion procedures2,” said John Devine, Invibio Medical business director. “In addition, the results presented confirm that the partnerships we have forged with device manufacturers and surgeons are pioneering approaches that are leading to positive results for patients.”